Electromed Return on Tangible Equity 2010-2024 | ELMD
Current and historical return on tangible equity values for Electromed (ELMD) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Electromed Return On Tangible Equity Historical Data |
Date |
TTM Net Income |
Tangible Equity |
Return on Tangible Equity |
2024-12-31 |
$0.01B |
$0.04B |
14.12% |
2024-09-30 |
$0.01B |
$0.04B |
14.37% |
2024-06-30 |
$0.01B |
$0.04B |
12.20% |
2024-03-31 |
$0.00B |
$0.04B |
10.19% |
2023-12-31 |
$0.00B |
$0.04B |
10.60% |
2023-09-30 |
$0.00B |
$0.04B |
8.22% |
2023-06-30 |
$0.00B |
$0.04B |
8.45% |
2023-03-31 |
$0.00B |
$0.04B |
5.76% |
2022-12-31 |
$0.00B |
$0.04B |
5.88% |
2022-09-30 |
$0.00B |
$0.03B |
5.97% |
2022-06-30 |
$0.00B |
$0.03B |
6.06% |
2022-03-31 |
$0.00B |
$0.03B |
6.15% |
2021-12-31 |
$0.00B |
$0.03B |
3.10% |
2021-09-30 |
$0.00B |
$0.03B |
3.13% |
2021-06-30 |
$0.00B |
$0.03B |
6.35% |
2021-03-31 |
$0.00B |
$0.03B |
9.68% |
2020-12-31 |
$0.00B |
$0.03B |
13.22% |
2020-09-30 |
$0.00B |
$0.03B |
13.68% |
2020-06-30 |
$0.00B |
$0.03B |
14.16% |
2020-03-31 |
$0.00B |
$0.03B |
14.81% |
2019-12-31 |
$0.00B |
$0.03B |
11.65% |
2019-09-30 |
$0.00B |
$0.03B |
8.16% |
2019-06-30 |
$0.00B |
$0.03B |
4.26% |
2019-03-31 |
$0.00B |
$0.02B |
4.40% |
2018-12-31 |
$0.00B |
$0.02B |
4.60% |
2018-09-30 |
$0.00B |
$0.02B |
4.82% |
2018-06-30 |
$0.00B |
$0.02B |
5.00% |
2018-03-31 |
$0.00B |
$0.02B |
5.26% |
2017-12-31 |
$0.00B |
$0.02B |
10.96% |
2017-09-30 |
$0.00B |
$0.02B |
11.43% |
2017-06-30 |
$0.00B |
$0.02B |
11.94% |
2017-03-31 |
$0.00B |
$0.02B |
6.25% |
2016-12-31 |
$0.00B |
$0.02B |
0.00% |
2016-09-30 |
$0.00B |
$0.02B |
6.67% |
2016-06-30 |
$0.00B |
$0.02B |
7.02% |
2016-03-31 |
$0.00B |
$0.02B |
7.27% |
2015-12-31 |
$0.00B |
$0.01B |
7.55% |
2015-09-30 |
$0.00B |
$0.01B |
0.00% |
2015-06-30 |
$0.00B |
$0.01B |
0.00% |
2015-03-31 |
$0.00B |
$0.01B |
0.00% |
2014-12-31 |
$0.00B |
$0.01B |
-8.33% |
2014-09-30 |
$0.00B |
$0.01B |
-8.51% |
2014-06-30 |
$0.00B |
$0.01B |
-8.33% |
2014-03-31 |
$0.00B |
$0.01B |
-8.16% |
2013-12-31 |
$0.00B |
$0.01B |
0.00% |
2013-09-30 |
$0.00B |
$0.01B |
0.00% |
2013-06-30 |
$0.00B |
$0.01B |
0.00% |
2013-03-31 |
$0.00B |
$0.01B |
0.00% |
2012-12-31 |
$0.00B |
$0.01B |
0.00% |
2012-09-30 |
$0.00B |
$0.01B |
0.00% |
2012-06-30 |
$0.00B |
$0.01B |
0.00% |
2012-03-31 |
$0.00B |
$0.01B |
0.00% |
2011-12-31 |
$0.00B |
$0.01B |
0.00% |
2011-09-30 |
$0.00B |
$0.01B |
0.00% |
2011-06-30 |
$0.00B |
$0.01B |
0.00% |
2011-03-31 |
$0.00B |
$0.01B |
0.00% |
2010-12-31 |
$0.00B |
$0.01B |
0.00% |
2010-09-30 |
$0.00B |
$0.01B |
0.00% |
2010-06-30 |
$0.00B |
$0.01B |
0.00% |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
MED INSTRUMENTS |
$0.199B |
$0.055B |
Electromed, Inc. manufactures, markets and sells products that provide airway clearance therapy to patients with compromised pulmonary function. The Company is the designer, manufacturer and worldwide provider of the SmartVest? Airway Clearance System and related products. The patented system uses High Frequency Chest Wall Oscillation (HFCWO), an alternative to Chest Physiotherapy (CPT), to deliver airway clearance treatment. The Company manufactures its products for use by chronically-ill patients who face health risks due to pneumonia and mucus accumulation in the lungs, particularly patients with cystic fibrosis, chronic obstructive pulmonary disease (COPD), bronchiectasis, and neuro-muscular disorders. The purpose of its primary product, the SmartVest System, is to loosen, mobilize, and release respiratory secretions from the lungs. The Company's products are primarily used in the home health care market and in hospitals. Electromed, Inc. is headquartered in New Prague, Minnesota.
|